e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Diagnosis and management of pleural and mediastinal diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Analysis of amylase rich pleural effusions
S. Turkeli, A. Atici, S. Kayhan (Rize, Samsun, Turkey)
Source:
Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Session:
Diagnosis and management of pleural and mediastinal diseases
Session type:
Thematic Poster Session
Number:
2939
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Turkeli, A. Atici, S. Kayhan (Rize, Samsun, Turkey). Analysis of amylase rich pleural effusions. Eur Respir J 2013; 42: Suppl. 57, 2939
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Challenges in the management of SCLC
Related content which might interest you:
Expression of YKL-40 and MIP-1a proteins in exudates and transudates: Biomarkers for differential diagnosis of pleural effusions?
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Association of biochemical determinants and fibrinous formation in malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Pleural complicationsin patients with chronic and end-stage renal disease
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014
Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
The role of a pleural service in optimising pleural disease management
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Biological markers of successful pleurodesis for malignant pleural effusion
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016
Screening potential biomarkers for idiopathic pulmonary fibrosis in bronchoalveolar lavage fluid
Source: International Congress 2014 – ILDs 1
Year: 2014
High fluorescence cells in pleural fluid. Association with pleural malignancy
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
Value of thoracoscopic pleural brush in the diagnosis of exudative pleural effusion
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014
Pleural disease
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019
Validity of Pleural Fluid Protein in differentiating Tuberculous from Malignant Pleural Effusion
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019
1,25-dihydroxyvitamin D in malignant and non-malignant pleural effusions
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
Pleural eicosanoids in patients with lung cancer
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
Malignant pleural effusion and incidence of pleural thickening in thorax CT
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Human beta defensin-2 serum levels are lower in complicated infectious pleural effusions
Source: Annual Congress 2013 –Interesting research questions
Year: 2013
Management of spontaneous pneumothorax in patients with or without Birt-Hogg-Dubé syndrome
Source: International Congress 2014 – ILDs 1
Year: 2014
Role of thoracoscopic pleural lavage and brush in undiagnosed exudative pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Yield of pleural cytology and macroscopic pleural invasion in metastatic pleural effusion
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias
Source: International Congress 2014 – IPF and surroundings
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept